Allosteric Bioscience, Inc. Targets Extending Longevity

Audio By Carbonatix

NEW YORK--(BUSINESS WIRE)--Mar 4, 2026--

Allosteric Bioscience, Inc. is delineating the Molecular Mechanism of Aging and Longevity with the goal of optimizing the aging process and extending longevity. It is utilizing Genomics, Biology, Genetics, Quantum Computing, Advanced Proprietary AI and Proprietary Molecular Technologies.

Select targets include Sarcopenia (muscle loss) prevention and treatment, Lamin A epigenetics, Tryptophan Metabolism, improved DNA repair, optimizing mitochondrial metabolism and control of factors comprising a Master Aging Complex identified by Dr. Arthur P. Bollon, who is President and Co-Founder of Allosteric Bioscience, Inc.

Dr. Bollon indicates that “Delineation of the Aging and Longevity Molecular Mechanism permits making modulators for key factors that will enhance the aging process, reduce aging related diseases and significantly extend longevity. We welcome inquires about our technologies and opportunities for collaboration and partnering”.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260304283832/en/

CONTACT: Dr. Arthur P. Bollon, President and Co-Founder of Allosteric Bioscience, Inc.,[email protected],[email protected], 469-585-7613.

Bruce Meyers, Executive Chairman and Co-Founder of Allosteric Bioscience, Inc.,[email protected], 469-391-7957.

www.allostericbioscience.com

KEYWORD: NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: RESEARCH TECHNOLOGY GENETICS HEALTH TECHNOLOGY OTHER HEALTH BIOTECHNOLOGY PHARMACEUTICAL HEALTH SCIENCE ARTIFICIAL INTELLIGENCE

SOURCE: Allosteric Bioscience, Inc.

Copyright Business Wire 2026.

PUB: 03/04/2026 07:56 PM/DISC: 03/04/2026 07:56 PM

http://www.businesswire.com/news/home/20260304283832/en